From bone biology to clinical outcome: state of the art and future perspectives.
about
Selectivity in bone targeting with multivalent dendritic polyanion dye conjugates.Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment.The association between oxidative stress and bone mineral density according to menopausal status of Korean womenStudies of the pharmacology of 17α-ethynyl-androst-5-ene-3β,7β,17β-triol, a synthetic anti-inflammatory androstene.Bisphosphonates and glucocorticoid-induced osteoporosis: cons.Inflammatory rheumatic disorders and bone.Glucocorticoids: bad or safe for the bones?The Effect of Polymorphisms in SPP1 on Risk of Fracture: A Case-Control Study.Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis.Association of systemic and intra-articular osteoclastogenic potential, pro-inflammatory mediators and disease activity with the form of inflammatory arthritis.Histone deacetylase inhibitors as suppressors of bone destruction in inflammatory diseases.Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.Osteoarthritis and osteoporosis: what is the overlap?Can bone loss in rheumatoid arthritis be prevented?Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis.Review: animal models as a tool to dissect pivotal pathways driving spondyloarthritis.Age- and Sex-Dependent Changes of Intra-articular Cortical and Trabecular Bone Structure and the Effects of Rheumatoid Arthritis.Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: bone mineral density measurements in a multicenter randomized clinical trial.Effect of celastrol on bone structure and mechanics in arthritic rats.Quantification and Impact of Secondary Osteoarthritis in Patients With Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis.PTH [1-34] enhances bone response around titanium implants in a rabbit model of osteoporosis.Glucocorticoids, Inflammation and Bone.Periarticular Bone Loss in Arthritis Is Induced by Autoantibodies Against Citrullinated Vimentin.Prevalence and associated factors of reduced bone mineral density in patients with idiopathic inflammatory myopathies.Are glucocorticoids harmful to bone in early rheumatoid arthritis?
P2860
Q31136234-2C291EBA-0E2C-445B-BF09-B1AC09CD4033Q33896725-C291FDF1-5962-4C97-9E47-8EDC3B437C34Q35003293-7C2F7F63-8E61-4BEF-810E-1D8576CD698DQ35040708-B54B142A-BA4B-4A65-8449-52049A5F7548Q35882427-1548E128-5D2F-47AA-88F6-70C05DFF7D7CQ35918747-3A5BA1D8-AA71-4CB2-8E0E-F1E0B33FC40BQ36246088-D397DB11-D979-4E95-A97C-EF3D778087B8Q36377357-B7A20F02-04D4-483B-B7F9-D980B8D98797Q37206612-5DDD4927-7CBD-4FB4-9376-0BEAF7E3FE9DQ37472160-B66DE248-30E3-4A0F-9F67-391776AA3947Q38008692-2ABB1B66-4118-4545-8D9E-585EBEF7C9DEQ38073889-0259275C-3A12-47B9-9024-7810F6B5C38BQ38091012-78A8DEF7-4EEC-41A3-AA4D-87B7348F7D39Q38115190-59355C85-777E-41B2-82AB-1E1D2BA8A233Q38218977-09768D0E-C8CA-4B95-B5F2-E5173A550EC0Q38555291-DDFA47D9-D467-430F-ABBF-E34AC4E3EB8BQ39243813-B9EC13FE-3CC8-4D01-AE5C-42C7C837369DQ39998140-3484859F-C56B-4DC1-A552-DD8552CA35CCQ41687137-7A0C2808-0B28-4FA7-AAE6-4214F25EF59CQ44213104-158BDF8C-43A3-4652-AC47-EF131BD764B9Q44405265-63461EA7-1CFB-4BB5-8859-6C0B6452BEF2Q50128187-E691E0F1-A329-47C8-9921-2267ACB82C44Q51046203-C0F7FC59-2A0E-4CB0-86DF-D0C934477DF9Q51139095-AEAF6AD6-E10E-4E91-A804-38FA1DBD14D5Q51741238-B2AF3809-C75A-4DF7-A16F-A9E841E35502
P2860
From bone biology to clinical outcome: state of the art and future perspectives.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
From bone biology to clinical outcome: state of the art and future perspectives.
@en
From bone biology to clinical outcome: state of the art and future perspectives.
@nl
type
label
From bone biology to clinical outcome: state of the art and future perspectives.
@en
From bone biology to clinical outcome: state of the art and future perspectives.
@nl
prefLabel
From bone biology to clinical outcome: state of the art and future perspectives.
@en
From bone biology to clinical outcome: state of the art and future perspectives.
@nl
P356
P1476
From bone biology to clinical outcome: state of the art and future perspectives.
@en
P2093
Johannes W J Bijlsma
Kenneth G Saag
P304
P356
10.1136/ARD.2010.135061
P407
P50
P577
2010-08-01T00:00:00Z